关于癌症缓解症治疗的最新情况
Kenichi Nishie1, Tomomi Nishie2, Seiichi Sato3
1Department of Respiratory Medicine, Iida Municipal Hospital, 438 Yawatamachi Iida Nagano, 395-0814, Japan; The First Department of Internal Medicine, Shinshu University School of Medicine, Japan.
癌症卡赫西亚是一种复杂的肌肉和脂肪损失综合征,显著影响癌症患者. 迫切需要有效的诊断和治疗策略来改善患者的治疗结果和生活质量.
科学领域:
- 在瘤学瘤学.
- 代谢过程中的代谢.
- 老年病的医生 老年病的医生
背景情况:
- 癌症缓解症是一种复杂的综合征,其特点是肌肉消耗,脂肪损失和食欲下降.
- 它显著损害了功能能力,降低了化疗耐受性,并降低了生活质量.
- 目前的营养干预措施不足以扭转这些有害变化.
研究的目的:
- 审查最近在理解和管理癌症缓解症方面的进展.
- 突出对有效的诊断和治疗策略的未满足需求.
- 强调新干预措施的潜力,以改善癌症患者的护理.
主要方法:
- 关于癌症缓存症的最近研究的文献综述.
- 分析已发表的指导方针和治疗方法.
- 综合当前关于病理生理学和临床影响的知识.
主要成果:
- 癌症缓解症涉及骨肌肉质量的减少和脂肪分解的增加.
- 减少食物摄入量是一个关键特征,加剧营养缺陷.
- 目前没有完全有效的干预措施可用,这代表了重大的临床挑战.
结论:
- 有效的策略用于癌症缓冲症的诊断和治疗是至关重要的.
- 在这个领域的进步可能会导致在整体癌症护理方面取得重大突破.
- 解决癌症缓解症对于改善患者的生存率和健康状况至关重要.
更多相关视频
06:32Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
